Viewing Study NCT06221189



Ignite Creation Date: 2024-05-06 @ 8:01 PM
Last Modification Date: 2024-10-26 @ 3:18 PM
Study NCT ID: NCT06221189
Status: WITHDRAWN
Last Update Posted: 2024-06-20
First Post: 2023-11-29

Brief Title: ACT-CSP for Family Caregivers of Palliative Care Patients
Sponsor: The Hong Kong Polytechnic University
Organization: The Hong Kong Polytechnic University

Study Overview

Official Title: An Acceptance and Commitment Therapy - Caregiver Support Program ACT-CSP for Family Caregivers of Patients Receiving Palliative Care A Feasibility Study
Status: WITHDRAWN
Status Verified Date: 2023-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: The end of the funding to the project on 30 April 2024
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of the study is to test the feasibility acceptability and preliminary efficacy of an acceptance and commitment therapy for supporting caregiver programme ACT-CSP on reduction of caregiver burden anxiety and depressive symptoms and enhancement of caregiving self-efficacy resilience and quality of life by ACT when compared to usual care for caregivers of palliative care patients
Detailed Description: This study will employ a pilot randomized controlled trial recruiting caregivers of palliative care patients to receive either a 3-week acceptance and commitment therapy for supporting caregiver programme ACT-CSP plus usual care n 15 or usual care only n 15 The components of acceptance and commitment therapy process will be emphasized in the intervention programme which include perspective taking self-as-context and defusion ie recognizing worry thoughts as thoughts only identifying values and acceptance of present-moment experience with respect to the values and committed action The ACT-CSP will be delivered by a trained ACT facilitator Participants will be followed up at Week 6 and Week 8 after recruitment to collect data for assessing the study objectives

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None